Marker Therapeutics, Inc., a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications…
Picosun Group delivers cutting-edge Atomic Layer Deposition (ALD) technology to ams OSRAM for volume manufacturing of optical semiconductor devices…
Exyte has successfully completed the construction of the first ExyCell® facility in China, the CliniMACS Cell Factory® of Miltenyi Biotec, a global provider of integrated solutions for Advanced Therapy Medical Products (ATMPs). The patented ExyCell technology was developed by Exyte as an end-to-end, integrated facility solution with standardized and modularized elements. These pre-configured and pre-fabricated modules enable fast-track construction thereby shortening time-to-market for new therapeutics and vaccines. The ExyCell facility is installed on the fourth floor of the ATLATL building located in the Zhangjiang High-Tech Park, and Miltenyi Biotec is now transferring production technology from Germany to China with regular operations for ATMP production is expected by autumn 2021. The facility will soon be open to visitors by appointment.
An international team of university researchers today reports solving a major fabrication challenge for perovskite cells — the intriguing potential challengers to silicon-based solar cells. These crystalline structures show great promise because they can absorb almost all wavelengths of light. Perovskite solar cells are already commercialized on a small scale, but recent vast improvements in their power conversion efficiency (PCE) are driving interest in using them as low-cost alternatives for solar panels.
A team headed by the TUM physicists Alexander Holleitner and Reinhard Kienberger has succeeded for the first time in generating ultrashort electric pulses on a chip using metal antennas only a few nanometers in size, then running the signals a few millimeters above the surface and reading them in again a controlled manner. The technology enables the development of new, powerful terahertz components.
Minakem’s HPAPI production will be carried out with an Occupational Exposure Limit (OEL) below 0,1μg/m3/8h. This emphasis on Environment, Health and Safety (EHS) reflects Minakem’s more than 20 years’ experience in continuously monitoring and controlling hazardous working environments, marking its leadership in this area.
Specifically, Zhu and his research team developed a solid polymer electrolyte that can be used in lithium ion batteries to replace the current liquid electrolyte to improve the safety and performance of lithium batteries.
Shire plc, the global biotechnology leader in rare diseases, announced today that the United States Food and Drug Administration (FDA) has approved the company’s first submission for its new plasma manufacturing facility near Covington, Georgia for the production of GAMMAGARD LIQUID® [Immune Globulin Infusion (Human)] 10% Solution, a replacement therapy for primary humoral immunodeficiency (PI).
covalent organic frameworks (COFs), were discovered in 2005, but their quality has been poor and preparation methods are uncontrolled. Now a Northwestern University research team is the first to produce high-quality versions of these materials, demonstrate their superior properties and control their growth. The researchers developed a two-step growth process that produces organic polymers with crystalline, two-dimensional structures.
A new experimental method permits the X-ray analysis of amyloids, a class of large, filamentous biomolecules which are an important hallmark of diseases such as Alzheimer’s and Parkinson’s. An international team of researchers headed by DESY scientists has used a powerful X-ray laser to gain insights into the structure of different amyloid samples.
qFLASH-A is a compact and economical 3D optical measurement system designed for use in smaller automated shop-floor inspection cells. Compatible with a wide range of industrial robots including small-load and collaborative robot systems, qFLASH-A measurement cells have a small footprint and offer an affordable way to automate dimensional data capture for all kinds of part.
Juniper Pharma Services (JPS), a Contract Development and Manufacturing Organisation (CDMO) specialising in the development of challenging small molecules, has announced a significant expansion to its UK-based drug development and clinical trial manufacturing facilities.